Search clinical trials for: calcineurin inhibitor

Total 64124 results

Panacea Biotec Ltd

Completed

Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fasting Condition

Healthy Volunteers

India
Technische Universität Dresden

Terminated

Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus

Graft vs Host Disease

Germany
Philipps University Marburg Medical Center

Active, not recruiting

Viral Load Guided Immunosuppression After Lung Transplantation (VIGILung)

Transplantation Lung

Austria, Germany
Peking Union Medical College Hospital

Completed

Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia Patients

Drug Effect | Aplastic Anemia

China
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients (OPIRUS)

Kidney Transplant

Korea, Republic of
Astellas Pharma Inc

Completed

A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in India

Liver Transplantation | Kidney Transplantation

India
Astellas Pharma Inc

Completed

Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment

Dermatitis, Atopic

France, Germany, Spain, Belgium, Netherlands, Finland, Austria, United Kingdom, Italy, Czech Republic, Switzerland, Portugal, Denmark
Chong Kun Dang Pharmaceutical

Completed

Bioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mg

Immunosuppression

Korea, Republic of
Novartis
Sandoz

Completed

Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients

Renal Transplant

United States
Nanjing University School of Medicine

Completed

Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy

Idiopathic Membranous Nephropathy

China
Panacea Biotec Ltd

Completed

Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fed Condition

Healthy Volunteers

India
moshe yeshurun

Unknown

Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease

Acute-graft-versus-host Disease

Israel
Fundación Canaria de Investigación Sanitaria

Recruiting

Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING)

Kidney Transplant Failure and Rejection

Spain
Loyola University
Veloxis Pharmaceuticals

Recruiting

Renal Tubular Injury and Transplant Outcomes in Cardiac Recipients Converting From IR Tacrolimus to XR Tacrolimus

Chronic Kidney Diseases | Heart Transplant

United States
Food and Drug Administration (FDA)
BioPharma Services USA

Completed

Bioequivalence Study of Tacrolimus in Healthy Volunteers

Healthy Volunteers

United States
Assiut University

Completed

Uses of Tacrolimus in Behcet Disease

Behcet Syndrome | Oral Ulcer

Egypt
Barbara Ann Karmanos Cancer Institute

Completed

Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT

Hematological Malignancies

United States
The Eye Center and The Eye Foundation for Research...

Unknown

Topical Tacrolimus in Vernal Keratoconjunctivitis

Vernal Keratoconjunctivitis

Saudi Arabia
Astellas Pharma Inc

Completed

A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis

Dermatitis, Atopic

United States
Astellas Pharma Inc

Completed

To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation. (RESTORE)

Kidney Transplantation

Belgium, France, Germany, Spain, Australia, Italy, Austria, Romania, United Kingdom, Poland, Hungary, Sweden, Netherlands, Czech Republic
Nanjing University School of Medicine
Sun Yat-sen University

Completed

To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN

Lupus Nephritis

China
Astellas Pharma Inc

Completed

Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis

Dermatitis

United States
Hospital Universitario Ramon y Cajal
Novartis; Astellas Pharma Inc

Unknown

Pharmacokinetic Study on the Combination of Everolimus-Tacrolimus

Kidney Diseases

Spain
University of Pisa

Recruiting

Tacrolimus Blood Concentration and Transplant-related Outcomes in Pediatric HSCT Recipients

Graft Vs Host Disease | Stem Cell Transplant Complications | Transplant Failure

Italy
University Hospital, Limoges

Unknown

PK Assessment of Tacrolimus Exposure Before and After a Switch From Twice Daily Immediate-release (Prograf®) to Once-daily Prolonged Release Tacrolimus (Envarsus®) (ENVARSWITCH)

Allograft

France
Astellas Pharma Europe Ltd.

Terminated

A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients (PROGRESSION)

Liver Transplantation | Kidney Transplantation | Heart Transplantation

Belgium, France, Germany, Poland, Spain, United Kingdom
Rabin Medical Center
Astellas Pharma Inc; Teva Pharma

Unknown

Incidence of Non Adherence to Treatment With Once-daily Formulation of Tacrolimus (Advagraf)

Medication Adherence

Israel
Norman Muirhead
Astellas Pharma Canada, Inc.

Completed

Advagraf/Prograf Conversion Trial (SG#153)

Renal Transplant | Kidney Pancreas Transplant

Canada
Sun Yat-sen University
First Affiliated Hospital, Sun Yat-Sen University

Unknown

Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients

Renal Transplantation

China
Pfizer

Completed

Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient

Kidney Transplantation

United States
Vanderbilt University Medical Center

Recruiting

Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns

Burn Injury

United States
University of Alberta

Recruiting

Extended-Release Tacrolimus Following Liver Transplantation

Cardiovascular Diseases | Renal Insufficiency | Metabolic Syndrome | Liver Transplant; Complications | Immunosuppressant Adverse Reaction

Canada
Heleen Grootjans
Chiesi Farmaceutici S.p.A.

Recruiting

Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation Patients (REVOLUTION)

Lung Transplant; Complications

Netherlands
Novartis Pharmaceuticals

Completed

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension (CONTRAIL I)

Liver Transplant Rejection

United States, Belgium, Germany, Spain, Argentina, Netherlands, Italy, Hungary, France, Czechia
Lorenzo Gallon

Completed

Extended Release Tacrolimus vs. Twice-Daily Tacrolimus

End Stage Renal Disease | Rejection of Renal Transplant

United States
Columbia University
Veloxis Pharmaceuticals

Active, not recruiting

Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation

Renal Transplant Rejection | Kidney Transplant Failure and Rejection

United States
NURIA LLOBERAS BLANCH

Completed

OPTImization of the Dose of tacroliMUS by Bayesian Prediction (OPTIMUS)

KIDNEY TRANSPLANTATION

Spain
Benha University

Completed

Corneal Densitometry Changes With Adenoviral SEI

Corneal Disease

United Arab Emirates
Chong Kun Dang Pharmaceutical

Unknown

Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients. (PK-TACT)

Kidney Transplant

Korea, Republic of
National Taiwan University Hospital
Astellas Pharma Taiwan, Inc.

Unknown

Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal Transplant

Adherence to Medication Regime

Taiwan
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients

Kidney Transplantation

United States
Veloxis Pharmaceuticals

Completed

Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant

Renal Failure

United States
Astellas Pharma Inc

Completed

Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment

Dermatitis, Atopic

France, United Kingdom, Spain, Belgium, Portugal, Netherlands, Finland, Czech Republic, Germany, Hungary, Italy
Medical University of Vienna

Completed

Tacrolimus During the Implantation and the Effect on Ischemia-reperfusion Injury in Liver Transplantation (TAC-Infusion)

Ischemia Reperfusion Injury

Austria
Uniwersytet Mikolaja Kopernika w Toruniu
Astellas Pharma Inc

Unknown

Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation

Kidney Transplantation

Poland
BeiGene

Recruiting

A Study to Evaluate the Safety and Efficacy of Zanubrutinib in Participants With Primary Membranous Nephropathy

Primary Membranous Nephropathy

China, United Kingdom, United States
University of California, Los Angeles
Veloxis Pharmaceuticals

Active, not recruiting

Envarsus XR® in Adolescent Renal Transplant Recipients (EnvarsusXR)

Kidney Transplantation | Renal Transplantation | Grafting, Kidney

United States
Chong Kun Dang Pharmaceutical

Unknown

Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM)

Kidney Transplant

Korea, Republic of
Novartis Pharmaceuticals

Completed

Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients (Spartacus)

Pharmacokinetics Study in de Novo Kidney Transplantation

Germany
Kyungpook National University Hospital

Unknown

The Effects of Conversion From Cyclosporine to Tacrolimus on the Changes of Cardiovascular Risk Profiles and Serum Metabolites in Renal Transplant Recipients

CYCLOSPORINE/TACROLIMUS

Korea, Republic of

Search clinical trials for: calcineurin inhibitor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations